2NO3

Novel 4-anilinopyrimidines as potent JNK1 Inhibitors


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 0.276 
  • R-Value Work: 0.206 
  • R-Value Observed: 0.233 

wwPDB Validation   3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies.

Liu, M.Wang, S.Clampit, J.E.Gum, R.J.Haasch, D.L.Rondinone, C.M.Trevillyan, J.M.Abad-Zapatero, C.Fry, E.H.Sham, H.L.Liu, G.

(2007) Bioorg Med Chem Lett 17: 668-672

  • DOI: 10.1016/j.bmcl.2006.10.093
  • Primary Citation of Related Structures:  
    2NO3

  • PubMed Abstract: 
  • A new series of 4-anilinopyrimidines has been synthesized and evaluated as JNK1 inhibitors. SAR studies led to the discovery of potent JNK1 inhibitors with good enzymatic activity as well as cellular potency represented by compound 2b. Kinase selectivity profile and the crystal structure of 2b are also described ...

    A new series of 4-anilinopyrimidines has been synthesized and evaluated as JNK1 inhibitors. SAR studies led to the discovery of potent JNK1 inhibitors with good enzymatic activity as well as cellular potency represented by compound 2b. Kinase selectivity profile and the crystal structure of 2b are also described.


    Related Citations: 
    • Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.
      Liu, M., Xin, Z., Clampit, J.E., Wang, S., Gum, R.J., Haasch, D.L., Trevillyan, J.M., Abad-Zapatero, C., Fry, E.H., Sham, H.L.
      (2006) Bioorg Med Chem Lett 16: 2590
    • Selective aminopyridine-based C-Jun N-terminal kinase inhibitors with cellular activiy
      Szczepankiewicz, B.G., Kosogof, C., Nelson, L.T.J., Liu, G., Zhao, H., Serby, M.D., Xin, Z., Liu, B., Gum, R.J., Haasch, D.
      (2006) J Med Chem 49: 3563
    • Discovery of Potent, Highly Selective and orally bioavailable Pyridine Carboxamide C-jun NH2-terminal kinase inhibitors
      Zhao, H., Serby, M.D., Xin, Z., Szczepankiewicz, B.G., Liu, M., Kosogof, C., Liu, B., Gum, R.J., Clampit, J.E., Haasch, D.L.
      (2006) J Med Chem 49: 4455

    Organizational Affiliation

    Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064-6098, USA. mei.liu@abbott.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Mitogen-activated protein kinase 8 AB370Homo sapiensMutation(s): 2 
Gene Names: MAPK8JNK1PRKM8SAPK1SAPK1C
EC: 2.7.11.24
Find proteins for P45983 (Homo sapiens)
Explore P45983 
Go to UniProtKB:  P45983
NIH Common Fund Data Resources
PHAROS:  P45983
Protein Feature View
Expand
  • Reference Sequence
  • Find similar proteins by:  Sequence   |   Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
C-JUN-AMINO-TERMINAL KINASE-INTERACTING protein 1 FG11N/AMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
859
Query on 859

Download Ideal Coordinates CCD File 
A, B
2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE
C17 H15 N5 O2
QHPKKGUGRGRSGA-UHFFFAOYSA-N
 Ligand Interaction
SO4
Query on SO4

Download Ideal Coordinates CCD File 
A, B
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
859IC50 :  9   nM  PDBBind
859IC50:  9   nM  BindingDB
859IC50:  170   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 0.276 
  • R-Value Work: 0.206 
  • R-Value Observed: 0.233 
  • Space Group: P 32 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 157.201α = 90
b = 157.201β = 90
c = 123.362γ = 120
Software Package:
Software NamePurpose
CNXrefinement
MAR345data collection
HKL-2000data reduction
HKL-2000data scaling
CNXphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2006-10-24 
  • Released Date: 2007-04-17 
  • Deposition Author(s): Abad-Zapatero, C.

Revision History  (Full details and data files)

  • Version 1.0: 2007-04-17
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2017-10-18
    Changes: Refinement description